Kobayashi Pharmaceutical Co., Ltd.

General ticker "KBYPF" information:

  • Sector: Consumer Staples
  • Industry: Household & Personal Products
  • Capitalization: $2.8B (TTM average)

Kobayashi Pharmaceutical Co., Ltd. does not follow the US Stock Market performance with the rate: -33.4%.

Estimated limits based on current volatility of 0.0%: low 34.62$, high 34.62$

Factors to consider:

  • Company pays dividends (annually): last record date 2025-06-30, amount 0.31$ (Y0.90%)
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [27.43$, 41.84$]
  • 2025-12-31 to 2026-12-31 estimated range: [28.97$, 43.99$]

Financial Metrics affecting the KBYPF estimates:

  • Positive: with PPE of 42.4 at the end of fiscal year the price was neutral
  • Positive: 7.86 < Operating profit margin, % of 15.01
  • Negative: Industry operating cash flow per share per price (median), % of 4.36 <= 5.52
  • Positive: Shareholder equity ratio, % of 80.44 > 63.39
  • Positive: 0.33 < Operating cash flow per share per price, % of 2.58
  • Negative: Inventory ratio change, % of 18.45 > 0.84

Similar symbols

Short-term KBYPF quotes

Long-term KBYPF plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue ¥166,258.00MM ¥173,455.00MM ¥165,600.00MM
Operating Expenses ¥139,589.00MM ¥147,675.00MM ¥140,740.00MM
Operating Income ¥26,669.00MM ¥25,780.00MM ¥24,860.00MM
Non-Operating Income ¥1,281.00MM ¥1,779.00MM ¥-10,946.00MM
Interest Expense ¥18.00MM ¥29.00MM ¥28.00MM
R&D Expense ¥8,327.00MM ¥9,004.00MM ¥9,109.00MM
Income(Loss) ¥27,950.00MM ¥27,559.00MM ¥13,914.00MM
Taxes ¥7,927.00MM ¥0.00MM ¥3,842.00MM
Profit(Loss)* ¥20,022.00MM ¥20,338.00MM ¥10,067.00MM
Stockholders Equity ¥197,899.00MM ¥204,816.00MM ¥213,466.00MM
Inventory ¥17,678.00MM ¥22,081.00MM ¥24,163.00MM
Assets ¥255,827.00MM ¥267,473.00MM ¥265,368.00MM
Operating Cash Flow ¥31,914.00MM ¥18,360.00MM ¥11,246.00MM
Capital expenditure ¥16,229.00MM ¥13,569.00MM ¥26,629.00MM
Investing Cash Flow ¥-14,312.00MM ¥-19,576.00MM ¥-18,415.00MM
Financing Cash Flow ¥-20,759.00MM ¥-19,463.00MM ¥-7,768.00MM
Earnings Per Share** ¥259.61 ¥268.16 ¥135.42

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.